The fully reviewed version will be posted as soon as it is available
The goal is maximum fat loss with minimum muscle loss, and that requires eating enough to fuel the process
MicroRNA 29b functions in acute myeloid leukemia
However, a database analysis of nearly 200,000 individuals treated with GLP-1RAs for diabetes, obesity or both identified a discontinuation rate of 36.5% at 12 months (30)
Our research is still ongoing, and WVU Medicine is helping lead the way
Compared to the control group, GLP-1RAs were associated with significant reductions in weight (mean difference (MD) = -5.70 kg, 95% confidence interval (CI): -9.52 to -1.88), BMI (MD = -2.94 kg/m 2 , 95% CI: -5.60 to -0.28), WC (MD = -3.66 cm, 95% CI: -4.89 to -2.43), glycated hemoglobin A1c (HbA1c) (standardized mean difference (SMD) = -0.73, 95% CI: -1.14 to -0.32), and systolic blood pressure (SBP) (MD = -3.62 mm Hg, 95% CI: -5.51 to -1.73) after cessation of therapy